News

Casino, sports betting and entertainment operator PENN Entertainment (NASDAQ:PENN) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.6% year on year to $1.67 billion. Its non-GAAP loss of $0.44 per share was 17.6% below analysts’ consensus estimates.

Healthcare services company Sotera Health (NASDAQ:) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 6.5% year on year to $290.2 million. Its non-GAAP profit of $0.21 per share was in line with analysts’ consensus estimates.

From memecoins to IPOs: Reflections from a dinner with top fintech and crypto firms.

Medication company Viatris (NASDAQ:VTRS) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 8.1% year on year to $3.53 billion. The company’s full-year revenue guidance of $13.75 billion at the midpoint came in 3.3% below analysts’ estimates. Its non-GAAP profit of $0.54 per share was 5.6% below analysts’ consensus estimates.

As the U.S. housing market continues to defy economic uncertainty, Westlake Corporation is benefiting from strong demand for building materials, even as its chemicals business struggles.

Eyewear retailer Warby Parker (NYSE:WRBY) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 17.8% year on year to $190.6 million. The company’s full-year revenue guidance of $885.5 million at the midpoint came in 1.5% above analysts’ estimates. Its GAAP loss of $0.06 per share was $0.01 below analysts’ consensus estimates.

Premium fitness club Life Time (NYSE:LTH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 18.7% year on year to $663.3 million. The company’s full-year revenue guidance of $2.95 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $0.27 per share was 30.1% above analysts’ consensus estimates.

Golf equipment and apparel company Acushnet (NYSE:GOLF) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 7.8% year on year to $445.2 million. The company’s full-year revenue guidance of $2.51 billion at the midpoint came in 1.3% below analysts’ estimates. Its GAAP loss of $0.02 per share was 93.9% above analysts’ consensus estimates.

Medical technology company Teleflex (NYSE:TFX) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 2.8% year on year to $795.4 million. Its non-GAAP profit of $3.89 per share was in line with analysts’ consensus estimates.

Shares of Snowflake surged 13% in premarket trading Thursday, a day after the cloud software provider reported better-than-estimated results and a buoyant outlook on booming demand for artificial intelligence products.